Spok Holdings (FRA:FQV) Research & Development: €10.8 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:FQV Spok Holdings Inc FRA:FQV
63 GF Score
Price €9.15
GF Value €12.82
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Spok Holdings Research & Development?

Spok Holdings FRA:FQV -0.54% 63 Research & Development is €10.8 Mil as of Mar. 2026. GuruFocus rates FRA:FQV with a GF Score™ of 63/100 and a GF Value™ of €12.82 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Spok Holdings's Research & Development for the three months ended in Mar. 2026 was €3.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €10.8 Mil.

Spok Holdings  (FRA:FQV) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Spok Holdings Research & Development Related Terms

Spok Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Spok Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spok Holdings Research & Development Chart

Spok Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.50 12.86 9.80 11.17 10.43

Spok Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.86 2.62 2.55 2.69 2.99
FRA:FQV
63GF Score
Spok Holdings Inc FRA:FQV
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Spok Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €10.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €10.8 Mil mean?
Spok Holdings (FRA:FQV) has a Research & Development of €10.8 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Spok Holdings and its competitors.
Is Spok Holdings' Research & Development too high?
Spok Holdings' current Research & Development is €10.8 Mil. Overall, Spok Holdings has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spok Holdings' Research & Development compare to LFMD and AMWL?
Spok Holdings' Research & Development of €10.8 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Spok Holdings and its competitors. Spok Holdings's current Research & Development is €10.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spok Holdings stock overvalued right now?
Based on GuruFocus' analysis, Spok Holdings (FRA:FQV) is currently considered Modestly Undervalued. The stock's GF Value™ is €12.82, compared to a current price of €9.15 — trading 28.6% below its estimated fair value. The current Research & Development is €10.8 Mil. Spok Holdings' overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Spok Holdings (FRA:FQV), the current Research & Development is €10.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Spok Holdings (FRA:FQV) Overvalued in 2026?

Based on GuruFocus' analysis, Spok Holdings stock appears to be undervalued. The current stock price of €9.15 is trading 28.6% below its estimated GF Value™ of €12.82. GuruFocus considers Spok Holdings to be Modestly Undervalued.

Key valuation signals for FRA:FQV:

  • Research & Development: €10.8 Mil
  • GF Value™: €12.82 vs. price of €9.15 (28.6% below fair value)
  • GF Score™: 63/100 with 3 warning signs

No single metric tells the full story. See the FRA:FQV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Spok Holdings Business Description

Other Exchanges SPOK:USA
Address 3000 Technology Drive, Suite 400, Plano, TX, USA, 75074
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.
63GF Score

Get the complete analysis for FRA:FQV

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.15
Price
€12.82
GF Value